Table 1 Patients and tumors’ characteristics from the PePiTA trial and CTC sub-study
| Â | All patients | Patients in CTC substudy |
|---|---|---|
Variable | ||
 Sample size No. | 53 | 36 |
Age No. years | ||
 Median | 67 | 67 |
 Range | 43–81 | 43–81 |
Gender No. (%) | ||
 Male | 32 (60) | 25 (69) |
 Female | 21 (40) | 11 (31) |
Stage | ||
 I/II | 9 (17) / 13 (25) | 4 (11)/9 (25) |
 III/IV | 27 (51) / 4 (8) | 20 (56)/ 3(8) |
Tumor Size No. (%) | ||
 T1 | 1 (2) | 1 (3) |
 T2 | 11 (21) | 5 (14) |
 T3-T4 | 41 (77) | 30 (83) |
Lymph node status No. (%) | ||
Negative | 22 (42) | 13 (36) |
Positive | 31 (58) | 23 (64) |